Related references
Note: Only part of the references are listed.WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
Alexandra Vaz et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2022)
Transparency practices at the FDA: A barrier to global health
Murray M. Lumpkin et al.
SCIENCE (2022)
Regulatory insight from low-income countries
Jackson K. Mukonzo et al.
SCIENCE (2022)
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
Jennifer E. Miller et al.
JAMA NETWORK OPEN (2021)
African-led health research and capacity building- is it working?
Victoria O. Kasprowicz et al.
BMC PUBLIC HEALTH (2020)
The WHO Global Benchmarking Tool: a game changer for strengthening national regulatory capacity
Javier Guzman et al.
BMJ GLOBAL HEALTH (2020)
Global migration of clinical research during the era of trial registration (vol 13, e0192413, 2018)
Paul K. Drain et al.
PLOS ONE (2018)
Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes
Jackson K. Mukonzo et al.
PLOS ONE (2014)
Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice
S-M Huang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Share Paper
